NCT05567198View on ClinicalTrials.gov

Gonadotropin-releasing Hormone Agonist (GnRHa) in Ovarian Preservation in SLE Subjects Receiving Cyclophosphamide as Determined by Questionnaires

RecruitingOBSERVATIONAL
Enrollment

100

Participants

Timeline

Start Date

March 3, 2023

Primary Completion Date

May 31, 2026

Study Completion Date

May 31, 2026

Conditions
Systemic Lupus Erythematosus (Sle)Primary Ovarian Insufficiency (Poi)
Trial Locations (1)

20892

RECRUITING

National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), Bethesda

All Listed Sponsors
lead

National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)

NIH